Evidence map›Paper›PMID 41778265›Full record

ArticlePulmonary circulation2026

The Pulmonary Hypertension Global Patient Survey: Groups 2 and 3.

Katherine Bunclark, Joseph Newman, Hakim Ghani, Shiv Munagala, Eva Otter, Gerald Fischer, Marcin Kurzyna, Gergely Meszaros, Millicent Stone, Shahin Moledina and 8 more

Abstract readLetter
In one paragraph

Article in Pulmonary circulation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Katherine BunclarkVictor Phillip Dahdaleh Heart & Lung Research Institute University of Cambridge Cambridge UK.ORCID https://orcid.org/0000-0002-8785-0715
Joseph NewmanVictor Phillip Dahdaleh Heart & Lung Research Institute University of Cambridge Cambridge UK.ORCID https://orcid.org/0000-0001-5514-0754
Hakim GhaniVictor Phillip Dahdaleh Heart & Lung Research Institute University of Cambridge Cambridge UK.ORCID https://orcid.org/0000-0002-0264-3355
Shiv MunagalaRoyal Statistical Society London UK.
Eva OtterPulmonary Hypertension Association Europe Vienna Austria.
Gerald FischerPulmonary Hypertension Association Europe Vienna Austria.
Marcin KurzynaEuropean Health Centre Otwock Otwock Poland.
Gergely MeszarosEuropean Reference Networks Lung Frankfurt Germany.
Millicent StoneTranslational Health Science, iOWNA London UK.
Shahin MoledinaGreat Ormond Street Hospital London UK.
Luke HowardHammersmith Hospital, Imperial College Healthcare NHS Trust London UK.
Wendy Gin-SingHammersmith Hospital, Imperial College Healthcare NHS Trust London UK.ORCID https://orcid.org/0000-0002-6993-0965
Pisana FerrariAlliance for Pulmonary Hypertension Brussels Belgium.
Maurice BeghettiChildren's University Hospital Geneva Geneva Switzerland.ORCID https://orcid.org/0000-0002-1841-0927
Mark ToshnerVictor Phillip Dahdaleh Heart & Lung Research Institute University of Cambridge Cambridge UK.
Matt GranatoPulmonary Hypertension Association Washington USA.
PH GPS Consortium
Joanna Pepke-ZabaVictor Phillip Dahdaleh Heart & Lung Research Institute University of Cambridge Cambridge UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this first global study of patient perspectives in Group 2 and 3 PH, we demonstrate that those with Group 3 PH report significantly greater adverse impacts on physical and mental wellbeing than those in Group 2 or Group 1, despite a lower treatment side-effect profile.

Indexed as

patient perspectivespatient‐reported outcome measurequality of life

Identifiers

PMID41778265
PMCPMC12951357

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.